Male Infertility.
Conditions
Interventions
Intervention group: This study is an intervention study and is not blinded, so all patients take the same type of medication and at the end of the study, their results are compared with the results at
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
20 Years to 45 Years
Inclusion criteria
Inclusion criteria: Age range 20 to 45 years
Exclusion criteria
Exclusion criteria: Endocrine disorders Autoimmune diseases Antisperm antibodies Obstructive and non-obstructive azoospermia Severe varicocele Cystic fibrosis Testicular cancers Use of antioxidant compounds or vitamins in the 8 weeks prior to study entry History of infertility treatment in the 8 weeks prior to study entry
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sperm parameters. Timepoint: At the beginning of the study (before the intervention) and 3 months after starting L-carnitine. Method of measurement: Sperm analysis using phase contrast microscopy.;The Sperm DNA Fragmentation. Timepoint: At the beginning of the study (before the intervention) and 3 months after starting L-carnitine. Method of measurement: Sperm DNA Fragmentation Assay (SDFA). | — |
Secondary
| Measure | Time frame |
|---|---|
| Sperm parameters. Timepoint: At the beginning of the study (before the intervention) and 3 months after starting L-carnitine. Method of measurement: Evaluation of sperm parameters using phase contrast microscopy.;The DNA fragmentation in sperm DNA genetic material. Timepoint: At the beginning of the study (before the intervention) and 3 months after starting L-carnitine. Method of measurement: Sperm DNA Fragmentation Assay (SDFA). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAzadeh Akbarisane
Iran University of Medical Sciences
Outcome results
None listed